Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms

Simon Mobach1,2,3, Nick D Bergkamp1, Ziliang Ma4,5

  • 1Department of Chemistry and Pharmaceutical Sciences, Division of Medicinal Chemistry, Amsterdam Institute for Molecular and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam 1081 HZ, The Netherlands.

Insights

CXCR4 receptor oligomers play a critical role in lymphoid cancers. Disrupting these CXCR4 oligomers inhibits cancer cell growth and enhances sensitivity to venetoclax therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Chemokine receptor CXCR4 is overexpressed in cancers, contributing to disease progression and therapy resistance.
  • CXCR4 oligomerization's role in malignancies is not well understood.
  • Targeting CXCR4 may offer therapeutic benefits in cancer treatment.

Purpose of the Study:

  • To investigate the functional relevance of CXCR4 oligomerization in lymphoid cancers.
  • To determine if disrupting CXCR4 oligomers impacts cancer cell signaling and drug sensitivity.
  • To explore the therapeutic potential of targeting CXCR4 oligomers.

Main Methods:

  • Utilized a nanobody-based BRET method to study endogenous CXCR4 oligomerization.
  • Analyzed changes in cell migration, prosurvival signaling, and phosphoproteome upon oligomer disruption.
  • Assessed the effect of oligomer disruption on chronic lymphocytic leukemia (CLL) spheroid growth and venetoclax sensitivity.

Main Results:

  • CXCR4 oligomerization correlated with increased expression in lymphoid cancer cell lines.
  • Disruption of CXCR4 oligomers reduced cell migration and prosurvival signaling.
  • Oligomer disruption inhibited primary CLL spheroid growth and sensitized malignant cells to venetoclax.

Conclusions:

  • CXCR4 oligomers play a noncanonical, critical role in lymphoid neoplasms.
  • Selective targeting of CXCR4 oligomers demonstrates clinical potential for sensitizing malignant B cells to venetoclax.
  • Disrupting CXCR4 oligomers represents a promising therapeutic strategy in lymphoid malignancies.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K